DB05533InvestigationalSmall molecule
QR-333 has been investigated as a treatment for diabetic peripheral neuropathy. QR-333 is a concentrated and standardized nutrient based active compounds dosed in a topical cream designed to reduce oxidative...
- Mechanism
- Curator reviewed
QR-333, a topical compound that contains quercetin, a flavonoid with aldose reductase inhibitor effects, ascorbyl palmitate, and vitamin D(3), was formulated to decrease the oxidative stress that contributes to peripheral diabetic neuropathy and thus alleviate its symptoms.
- Primary indication
- Investigated for use/treatment in neuropathy (diabetic).Curator reviewed
- Code names
- QR-333
Resolves to
Targets
What you can answer from here — as of April 02, 2025
Which drugs share a target with QR-333, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account